pentobarbital will decrease the level or influence of montelukast by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unfamiliar. Contraindicated (1)pentobarbital will lower the level or impact of lorlatinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. R